Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

PLUS THERAPEUTICS, INC. Director's Dealing 2013

Sep 9, 2013

34301_dirs_2013-09-09_8510f712-7c46-4d9f-9c29-98b5ca8ea583.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CYTORI THERAPEUTICS, INC. (CYTX)
CIK: 0001095981
Period of Report: 2013-09-06

Reporting Person: RICKEY DAVID (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2013-09-06 Common Stock P 1000 $2.2699 Acquired 111559 Indirect
2013-09-06 Common Stock P 2000 $2.27 Acquired 188976 Indirect
2013-09-09 Common Stock P 2000 $2.37 Acquired 190976 Indirect

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 34909 Indirect
Restricted Stock Award (Common Stock) 6100 Direct

Footnotes

F1: These shares are owned by the Dave Rickey and Daughters Foundation.

F2: These securities are owned by Dave Rickey, TTEE FBO the David Rickey Trust